← Browse by Condition
Medical Condition

hr her2 breast cancer

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06874933 Phase 2
Recruiting

Neoadjuvant Chemotherapy in Combination With Anlotinib and Benmelstobart for HR+/HER2- Breast Cancer (NEOTORCH-BREAST03)

Enrollment
35 pts
Location
China
Sponsor
First Affiliated Hospital of Z...
View Trial →